Literature DB >> 26909840

Long-Term Outcomes Following Lumbar Total Disc Replacement Using ProDisc-II: Average 10-Year Follow-Up at a Single Institute.

Se-Jun Park1, Chong-Suh Lee, Sung-Soo Chung, Keun-Ho Lee, Wan-Seok Kim, Jun-Young Lee.   

Abstract

STUDY
DESIGN: A retrospective analysis.
OBJECTIVE: To evaluate the long-term clinical and radiographic outcomes and to investigate who achieved the successful outcomes after lumbar total disc replacement (TDR) using ProDisc II. SUMMARY OF BACKGROUND DATA: There are few evidences regarding the long-term efficacy and safety of TDR. Furthermore, it has not been addressed which patients achieved good outcomes in long-term follow-up.
METHODS: Data at 1-, 2-, 5-, 7-year, and last follow-up were used for the analysis. According to the presence of combined pathologies, patients were categorized as groups A and B (presumed good and bad candidates, respectively). Clinical outcomes were evaluated using visual analog scale, Oswestry Disability Index, clinical success rate, and subjective satisfaction (four-point scale). Radiographic results included segmental range of motion.
RESULTS: Total study population was 54 patients with 69 segments with the average follow-up duration of 120.0 months. There were 39 patients in group A and 15 in group B. Visual analog scale and Oswestry Disability Index scores were improved significantly at all follow-up periods, reaching maximal improvement at the postoperative 2 years. Clinical success rate and satisfaction rate were significantly higher in group A (76.9% and 87.2%, respectively) than those in group B (40.0% and 60.0%, respectively) at the last follow-up. Five patients (9.3%) required revision fusion surgeries, and they are all in group B. The final segmental range of motion was well maintained in monosegmental TDR, but not in bisegmental TDR.
CONCLUSION: Lumbar TDR using Prodisc II showed the successful outcomes with the clinical success rate of 76.9% and the satisfaction rate of 87.2% when the patients were presumed as good candidate for TDR. However, the patients who had the combined pathologies showed suboptimal results with high risk of the revision surgeries. Thus, the strict patient selection process is mandatory for the successful outcomes. LEVEL OF EVIDENCE: 4.

Entities:  

Mesh:

Year:  2016        PMID: 26909840     DOI: 10.1097/BRS.0000000000001527

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  6 in total

Review 1.  Lumbar disc replacement surgery-successes and obstacles to widespread adoption.

Authors:  Stephan N Salzmann; Nicolas Plais; Jennifer Shue; Federico P Girardi
Journal:  Curr Rev Musculoskelet Med       Date:  2017-06

2.  Lumbar total disc replacement: predictors for long-term outcome.

Authors:  Håvard Furunes; Christian Hellum; Jens Ivar Brox; Ivar Rossvoll; Ansgar Espeland; Linda Berg; Helga Maria Brøgger; Milada Cvancarova Småstuen; Kjersti Storheim
Journal:  Eur Spine J       Date:  2017-11-04       Impact factor: 3.134

3.  We Need to Talk about Lumbar Total Disc Replacement.

Authors:  Stephen Beatty
Journal:  Int J Spine Surg       Date:  2018-08-03

Review 4.  Lumbar total disc arthroplasty: outdated surgery or here to stay procedure? A systematic review of current literature.

Authors:  Matteo Formica; Stefano Divano; Luca Cavagnaro; Marco Basso; Andrea Zanirato; Carlo Formica; Lamberto Felli
Journal:  J Orthop Traumatol       Date:  2017-07-06

5.  National Trends for Primary and Revision Lumbar Disc Arthroplasty Throughout the United States.

Authors:  Comron Saifi; Alejandro Cazzulino; Caroline Park; Joseph Laratta; Philip K Louie; Jamal N Shillingford; Ronald Lehman; Howard An; Frank Phillips
Journal:  Global Spine J       Date:  2017-10-25

6.  Long-Term Residual-Mobility and Adjacent Segment Disease After Total Lumbar Disc Replacement.

Authors:  Joep Kitzen; Timon F G Vercoulen; Martijn G M Schotanus; Sander M J van Kuijk; Nanne P Kort; Lodewijk W van Rhijn; Paul C P H Willems
Journal:  Global Spine J       Date:  2020-07-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.